Markets

Faeth Therapeutics To Conduct Virtual Event On Nov. 9 To Present Topline Data From Its Phase 2 PIK-2-1 Study Of PIKTOR To Treat Endometrial Cancer

Nov 6, 2026 · 04:02 PM ET· updated 26m ago

Faeth Therapeutics (NASDAQ:FTH), a clinical- stage biotechnology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that it will host a virtual event on

Why It Matters

Faeth Therapeutics will show early research results on November 9. Pay attention to whether doctors think the medicine is helping patients.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

FTH23.06

+3.13 (+15.74%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.